Armata Pharmaceuticals (ARMP) closed at $3.72 on November 12, 2026, down 4.4% from the previous close, on volume of 101,817 shares (30-day average 87,741).
Data as of November 12, 2026.
Wall Street Analysts Are Bullish on Top Healthcare Picks
TipRanks (Fri, 13-Nov 9:01 AM ET)
Armata Pharmaceuticals GAAP EPS of -$0.24 beats by $0.32, revenue of $3.17M beats by $2.72M
Seeking Alpha News (Thu, 12-Nov 4:59 PM ET)
PRNewswire (Thu, 12-Nov 4:05 PM ET)
PRNewswire (Wed, 7-Oct 7:00 AM ET)
PRNewswire (Wed, 23-Sep 7:00 AM ET)
PRNewswire (Mon, 21-Sep 7:00 AM ET)
Armata Pharmaceuticals Receives U.S. FDA Breakthrough Therapy Designation for AP-SA02
PRNewswire (Mon, 14-Sep 7:01 AM ET)
PRNewswire (Thu, 10-Sep 7:00 AM ET)
PRNewswire (Thu, 3-Sep 7:00 AM ET)
Market Chameleon (Tue, 13-Jan 2:51 AM ET)
Armata Pharmaceuticals Inc is a late clinical-stage biotechnology company focused on the development of high-purity and potent, pathogen-specific bacteriophage therapeutics for the treatment of antibiotic-resistant and difficult-to-treat bacterial infections using proprietary bacteriophage-based technology. It has completed three Phase 2 clinical trials to date. The Company operates and manages its business as one reportable operating segment, which is the business of developing pathogen-specific bacteriophage therapeutics for the treatment of antibiotic-resistant and difficult-to-treat acute and chronic bacterial infections using its proprietary bacteriophage-based technology.
Armata Pharmaceuticals trades on the AMEX stock market under the symbol ARMP.
As of November 13, 2026, ARMP stock price was flat at $3.72 with 366 million shares trading.
ARMP has a beta of -0.10, meaning it tends to be less sensitive to market movements. ARMP has a correlation of 0.00 to the broad based SPY ETF.
ARMP has a market cap of $138.32 million. This is considered a Micro Cap stock.
Last quarter Armata Pharmaceuticals reported $3 million in Revenue and -$.24 earnings per share. This beat revenue expectation by $3 million and exceeded earnings estimates by $.32.
In the last 3 years, ARMP traded as high as $16.34 and as low as $.90.
The top ETF exchange traded funds that ARMP belongs to (by Net Assets): VTI, IWM, VXF, IWO, VTWO.
ARMP has underperformed the market in the last year with a return of -44.4%, while the SPY ETF gained +11.6%. In the last 3 month period, ARMP fell short of the market, returning -13.7%, while SPY returned -2.0%. However, in the most recent 2 weeks ARMP has outperformed the stock market by returning +14.5%, while SPY returned -1.8%.
ARMP support price is $3.40 and resistance is $4.04 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that ARMP shares will trade within this expected range on the day.
